Ageing and ART: a waste of time and money?

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 21, Issue 1, 2007, Pages 5-20

  NG, Ernest Hung Yu ^a   HO, Pak Chung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ageing; assisted reproductive technology; prediction of ovarian response; pregnancy rate

Indexed keywords

FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; GROWTH HORMONE; INHIBIN B; NITRIC OXIDE DONOR;

AGING; CHROMOSOME ABERRATION; CONCEPTION; CRYOPRESERVATION; ECHOGRAPHY; FEMALE FERTILITY; FERTILIZATION IN VITRO; FINANCIAL MANAGEMENT; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; MEDICAL DECISION MAKING; OOCYTE DONATION; OVARY FOLLICLE; OVULATION INDUCTION; PREDICTION; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANCY RATE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SPONTANEOUS ABORTION; TIME; TREATMENT OUTCOME;

ADULT; FEMALE; FERTILITY; HUMANS; MATERNAL AGE; MIDDLE AGED; PREGNANCY; PREGNANCY RATE; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 33847306067     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2006.09.004     Document Type: Review

References (99)

1. Leridon H. Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum Reprod 19 (2004) 1548-1553
2. Block E. Quantitative morphological investigations of the follicular system in women. Variation at different ages. Acta Anat 14 (1952) 108-123
3. Baker T.G. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond 158 (1963) 417-433
4. Richardson S.J., Senikas V., and Nelson J.F. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhausation. J Clin Endocrinol Metab 65 (1987) 1231-1237
5. Gougeon A., Elochard R., and Thalabard J.C. Age-related changes of the population of human ovarian follicles: increase in the disappearance rate on non-growing and early growing follicles in ageing women. Biol Reprod 50 (1994) 653-661
6. Faddy M.J., and Gosden R.G. A mathematical model of follicle dynamics in the human ovary. Hum Reprod 10 (1995) 770-775
7. Sneider H., MacGregor A.J., and Spector T.D. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 83 (1998) 1875-1880
8. Johnson J., Canning J., Kaneko T., et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 428 (2004) 145-150
9. Pal L., and Santoro N. Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev 1 (2002) 413-423
10. Toner J.P., Grainger D.A., and Frazier L.M. Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience, 1996-1998. Fertil Steril 78 (2002) 1038-1045
11. Menken J., Trussell J., and Larsen U. Age and infertility. Science 233 (1986) 1389-1394
12. Schwartz D., and Mayaux M.J. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med 18 (1982) 404-406
13. Nybo Andersen A.M., Wohlfahrt J., Christens P., et al. Maternal age and fetal loss: population based register linkage study. BMJ 320 (2000) 1708-1712
14. Hook E.B., Cross P.K., and Schreinemachers D.M. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 249 (1983) 2034-2038
15. Gilbert W.M., Nesbitt T.S., and Danielsen B. Childbearing beyond age 40: pregnancy outcome in 24,032 cases. Obstet Gynecol 93 (1999) 9-14
16. Jacobsson B., Ladfors L., and Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol 104 (2004) 727-733
17. Cleary-Goldman J., Malone F.D., Vidaver J., et al. Impact of maternal age on obstetric outcome. Obstet Gynecol 105 (2005) 983-990
18. Duran H.E., Morshedi M., Kruger T., et al. Intrauterine insemination: a systematic review on determinants of success. Hum Reprod Update 8 (2002) 373-384
19. Makker G., Ng E.H.Y., Yeung W.S.B., et al. Prognostic factors for successful outcome in patients undergoing controlled ovarian stimulation and intrauterine insemination. Hong Kong Med J 9 (2003) 341-345
20. Andersen A.N., Gianaroli L., Felberbaum R., et al. Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Hum Reprod 20 (2005) 1158-1176
21. Frederick J.L., Denker M.S., Rojas A., et al. Is there a role for ovarian stimulation and intra-uterine insemination after age 40?. Hum Reprod 9 (1994) 2284-2286
22. Corsan G., Trias A., Trout S., et al. Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile?. Hum Reprod 11 (1996) 1109-1112
23. Nougjua-Huttunen S., Tomas C., Bloigu R., et al. Intrauterine insemination treatment in subfertility: an analysis of factor affecting outcome. Hum Reprod 14 (1999) 698-703
24. Stone B.A., Vargyas J.M., Ringler G.E., et al. Determinants of the outcome of intrauterine insemination: analysis of outcomes of 9963 consecutive cycles. Am J Obstet Gynecol 180 (1999) 1522-1534
25. Haebe J., Martin J., Tekepety F., et al. Success of intrauterine insemination in women aged 40-42 years. Fertil Steril 78 (2002) 29-33
26. Templeton A., Morris J.K., and Parslow W. Factors that affect outcome of in-vitro fertilization treatment. Lancet 348 (1996) 1402-1406
27. Society for Assisted Reproductive Technology, and American Society for Reproductive Medicine. Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 81 (2004) 1207-1220
28. Grimbizis G., Vandervorst M., Camus M., et al. Intracytoplasmic sperm injection, results in women older than 39, according to age and the number of embryos replaced in selective or non-selective transfers. Hum Reprod 13 (1998) 884-889
29. Lass A., Croucher C., Duffy S., et al. One thousand initiated cycles of in vitro fertilization in women > or = 40 years of age. Fertil Steril 70 (1998) 1030-1034
30. Ron-El R., Raziel A., Strassburger D., et al. Outcome of assisted reproductive technology in women over the age of 41. Fertil Steril 74 (2000) 471-475
31. Klipstein S., Regan M., Ryley D.A., et al. One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above. Fertil Steril 84 (2005) 435-445
32. Sharif K., Elgendy M., Lashen H., et al. Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynaecol 105 (1998) 107-112
33. Sharara F.I., Scott Jr. R.T., and Seifer D.B. The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol 179 (1998) 804-812
34. Bancsi L.F., Broekmans F.J., Mol B.W., et al. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril 79 (2003) 1091-1100
35. Van Montfrans J.M., Hoek A., van Hooff M.H.A., et al. Predictive value of basal follicle-stimulating hormone concentrations in a general subfertility population. Fertil Steril 74 (2000) 97-103
36. Seifer D.B., MacLaughin D.T., Christian B.P., et al. Early follicular serum Müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77 (2002) 468-471
37. Van Rooij I.A.J., Broekmans F.J.M., te Velde E.R., et al. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17 (2002) 3065-3071
38. Fanchin R., Schonäuer L.M., Righini C., et al. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18 (2003) 323-327
39. Seifer D.B., Scott Jr. R.T., Bergh P.A., et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril 72 (1999) 63-65
40. Corson S.L., Gutmann J., Batzer F.R., et al. Inhibin-B as a test of ovarian reserve for infertile women. Hum Reprod 14 (1999) 2818-2821
41. Hall J.E., Welt C.K., and Cramer D.W. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 14 (1999) 409-415
42. Tinkanen H., Bläuer M., Laippala P., et al. Prognostic factors in controlled ovarian hyperstimulation. Fertil Steril 72 (1999) 932-936
43. Creus M., Peñarrubia J., Fábregues F., et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 15 (2000) 2341-2346
44. Dzik A., Lambert-Messerlian G., Izzo V.M., et al. Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. Fertil Steril 74 (2000) 1114-1117
45. Syrop C.H., Willhoite A., and Van Voorhis B.J. Ovarian volume: a novel outcome predictor for assisted reproduction. Fertil Steril 64 (1995) 1167-1171
46. Lass A., Skull J., McVeigh E., et al. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin for in-vitro fertilization can predict poor response. Hum Reprod 12 (1997) 294-297
47. Tomás C., Nuojua-Huttunen S., and Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 12 (1997) 220-223
48. Chang M.Y., Chiang C.H., Hsieh T.T., et al. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 69 (1998) 505-510
49. Ng E.H.Y., Tang O.S., and Ho P.C. The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an in-vitro fertilization programme. Hum Reprod 15 (2000) 1937-1942
50. Frattarelli J.L., Lauria-Costa D.F., Miller B., et al. Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertil Steril 74 (2000) 512-517
51. Hsieh Y.Y., Chang C.C., and Tsai H.D. Antral follicle counting in predicting the retrieved oocyte number after ovarian hyperstimulation. J Assist Reprod Genet 18 (2001) 320-324
52. Kupesic S., and Kurjak A. Predictors of IVF outcome by three-dimensional ultrasound. Hum Reprod 17 (2002) 950-955
53. Popovic-Todorovic B., Loft A., Lindhard A., et al. A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum Reprod 18 (2003) 781-787
54. Klinkert E.R., Broekmans F.J., Looman C.W., et al. Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod 20 (2005) 611-615
55. Reuss M.L., Kline J., Santos R., et al. Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol 174 (1996) 624-627
56. Scheffer G.J., Broekmans F.J.M., Dorland M., et al. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 72 (1999) 845-851
57. Ng E.H.Y., Fong D.Y.T., Yeung W.S.B., et al. Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility. Hum Reprod 18 (2003) 2169-2174
58. Zaidi J., Barber J., Kyei-Mensah A., et al. Relationship of ovarian stromal blood flow at the baseline ultrasound scan to subsequent follicular response in an in vitro fertilization program. Obstet Gynecol 88 (1996) 779-784
59. Engmann L., Sladkevicius P., Agrawal R., et al. Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment. Fertil Steril 71 (1999) 22-29
60. Ng E.H.Y., Tang O.S., Chan C.C.W., et al. Ovarian stromal blood flow in the prediction of ovarian response during in vitro fertilization treatment. Hum Reprod 20 (2005) 3147-3151
61. Ng E.H.Y., Chan C.C.W., Tang O.S., et al. Ovarian stromal vascularity is not predictive of ovarian response and pregnancy. Reprod Biomed Online 12 (2006) 43-49
62. Ng E.H.Y., Chan C.C.W., Yeung W.S.B., et al. Effect of age on ovarian stromal flow measured by three-dimensional ultrasound with power Doppler in Chinese women with proven fertility. Hum Reprod 19 (2004) 2132-2137
63. Keay S.D., Liversedge N.H., Mathur R.S., et al. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 104 (1997) 521-527
64. Karande V., and Gleicher N. A rational approach to the management of low responders in in-vitro fertilization. Hum Reprod 14 (1999) 1744-1748
65. Fasouliotis S.J., Simon A., and Laufer N. Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet. J Assist Reprod Genet 17 (2000) 357-373
66. Surrey E.S., and Schoolcraft W.B. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 73 (2000) 667-676
67. Mahutte N.G., and Arici A. Poor responders: does the protocol make a difference?. Curr Opin Obstet Gynecol 14 (2002) 275-281
68. Tarlatzis B.C., Zepiridis L., Grimbizis G., et al. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 9 (2003) 61-76
69. Kotarba D., Kotarba J., and Hughes E. Growth Hormone for In Vitro Fertilization (Cochrane Review). In. The Cochrane Library Issue 1 (2003) Oxford: Update Software
70. Battaglia C., Salvatori M., Maxia N., et al. Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. Hum Reprod 14 (1999) 1690-1697
71. Karande V.C., Jones G.S., Veeck L.L., et al. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve in vitro fertilization outcome in low responder patients. Fertil Steril 53 (1990) 486-489
72. Land J.A., Yarmolinskaya M.I., Dumoulin J.C.M., et al. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 65 (1996) 961-965
73. Feldberg D., Farhi J., Ashkenazi J., et al. Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 62 (1994) 343-346
74. Garcia-Velasco J.A., Isaza V., Requena A., et al. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod 15 (2000) 2292-2296
75. Akman M.A., Erden H.F., Tosun S.B., et al. Addition of GnRH antagonist in cycles of poor responders undergoing IVF. Hum Reprod 15 (2000) 2145-2147
76. Kolibianakis E., Albano C., Zikopoulos K., et al. GnRH antagonists in poor responders. Acta Obstet Gynecol Scand 83 (2004) 1216-1217
77. Cheung L.P., Lam P.M., Lok I.H., et al. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial. Hum Reprod 20 (2005) 616-621
78. Schmidt D.W., Bremner T., Orris J.J., et al. A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertil Steril 83 (2005) 1568-1571
79. Edi-Osagie E., Hooper L., and Seif M.W. The impact of assisted hatching on live birth rates and outcomes of assisted conception: a systematic review. Hum Reprod 18 (2003) 1828-1835
80. Sallam H.N., Sadek S.S., and Agameya A.F. Assisted hatching - a meta-analysis of randomized controlled trials. J Assist Reprod Genet 20 (2003) 332-342
81. Gianaroli L., Magli M.C., Ferraretti A.P., et al. Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. Fertil Steril 72 (1999) 837-844
82. Munne S., Sandalinas M., Escudero T., et al. Improved implantation after preimplantation genetic diagnosis of aneuploidy. Reprod Biomed Online 7 (2003) 91-97
83. Munne S., Magli C., Cohen J., et al. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum Reprod 14 (1999) 2191-2199
84. Staessen C., Platteau P., Van Assche E., et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 19 (2004) 2849-2858
85. Stevens J., Wale P., Surrey E.S., et al. Is aneuploidy screening for patients aged 35 or over beneficial? A prospective randomized trial. Fertil Steril 82 supplement 2 (2004) 249
86. Twisk M., Mastenbroek S., van Wely M., et al. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database Syst Rev (2006) CD005291
87. Cohen J., Scott R., Schimmel T., et al. Birth of infant after transfer of anucleate donor oocyte cytoplasm into recipient eggs. Lancet 350 (1997) 186-187
88. Barritt J.A., Willadsen S., Brenner C., et al. Epigenetic and experimental modifications in early mammalian development. Part II. Cytoplasmic transfer in assisted reproduction. Hum Reprod Update 7 (2001) 428-435
89. Fabbri R., Porcu E., Marsella T., et al. Human oocytes cryopreservation: new perspectives regarding oocyte survival. Hum Reprod 16 (2001) 411-416
90. Borini A., Bonu M.A., Coticchio G., et al. Pregnancies and births after oocyte fertilization. Fertil Steril 82 (2004) 601-605
91. Oktay K., and Karlikaya G. Ovarian function after transplantation of frozen banked autologous ovarian tissue. N Engl J Med 342 (2000) 1919
92. Tryde Schmidt K.L., Yding Andersen C., Starup J., et al. Orthotopic autotransplantation of cryopreserved ovarian tissue to a woman cured of cancer - follicular growth, steroid production and oocyte retrieval. Reprod Biomed Online 8 (2004) 448-453
93. Oktay K., Economos K., Kan M., et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA 286 (2001) 1490-1493
94. Oktay K., Buyuk E., Veeck L., et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363 (2004) 837-840
95. Donnez J., Dolmans M.M., Demylle D., et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364 (2004) 1405-1410
96. Cohen M.A., Lindheim S.R., and Sauer M.V. Donor age is paramount to success in oocyte donation. Hum Reprod 14 (1999) 2755-2758
97. American Society for Reproductive Medicine. IFFS surveillance. Fertil Steril 81 supplement 4 (2004) S9-S54
98. Van Voorhis B.J., Sparks A.E., Allen B.D., et al. Cost-effectiveness of infertility treatments: a cohort study. Fertil Steril 67 (1997) 830-836
99. Suchartwatnachai C., Wongkularb A., Srisombut C., et al. Cost-effectiveness of IVF in women 38 years and older. Int J Gynaecol Obstet 69 (2000) 143-148